NANOG expression correlates with differentiation, metastasis and resistance to preoperative adjuvant therapy in oral squamous cell carcinoma
Tóm tắt
Từ khóa
Tài liệu tham khảo
Chen, 2004, Genome-wide profiling of oral squamous cell carcinoma, J Pathol, 204, 326, 10.1002/path.1640
Pentenero, 2005, Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature, Head Neck, 27, 1080, 10.1002/hed.20275
Myers, 2000, Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes, Otolaryngol Head Neck Surg, 122, 44, 10.1016/S0194-5998(00)70142-2
Chambers, 2003, Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells, Cell, 113, 643, 10.1016/S0092-8674(03)00392-1
Mitsui, 2003, The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells, Cell, 113, 631, 10.1016/S0092-8674(03)00393-3
Cavaleri, 2003, Nanog: a new recruit to the embryonic stem cell orchestra, Cell, 113, 551, 10.1016/S0092-8674(03)00394-5
Pan, 2007, Nanog and transcriptional networks in embryonic stem cell pluripotency, Cell Res, 17, 42, 10.1038/sj.cr.7310125
Ezeh, 2005, Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma, Cancer, 104, 2255, 10.1002/cncr.21432
Meng, 2010, Overexpression of nanog predicts tumor progression and poor prognosis in colorectal cancer, Cancer Biol Ther, 9, 295, 10.4161/cbt.9.4.10666
Xu, 2012, Nanog: a potential biomarker for liver metastasis of colorectal cancer, Dig Dis Sci, 57, 2340, 10.1007/s10620-012-2182-8
Matsuoka, 2012, Role of the stemness factor sox2, oct3/4, and nanog in gastric carcinoma, J Surg Res, 174, 130, 10.1016/j.jss.2010.11.903
Tsai, 2011, Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma, J Oral Pathol Med, 40, 621, 10.1111/j.1600-0714.2011.01015.x
Bourguignon, 2012, Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells, Oncogene, 31, 149, 10.1038/onc.2011.222
Chiou, 2008, Positive correlations of oct-4 and nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma, Clin Cancer Res, 14, 4085, 10.1158/1078-0432.CCR-07-4404
Zhang, 2010, A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy, Cancer Lett, 289, 151, 10.1016/j.canlet.2009.08.010
Sobin, 1997, International Union Against Cancer TNM classification of malignant tumors, 5th edition
Dalerba, 2007, Cancer Stem Cells: Models and Concepts, Annu Rev Med, 58, 267, 10.1146/annurev.med.58.062105.204854
Clarke, 2006, Cancer stem cells - perspectives on current status and future directions: AACR Workshop on cancer stem cells, Cancer Res, 66, 9339, 10.1158/0008-5472.CAN-06-3126
Costea, 2006, Cancer stem cells - new and potentially important targets for the therapy of oral squamous cell carcinoma, Oral Dis, 12, 443, 10.1111/j.1601-0825.2006.01264.x
Locke, 2005, Retention of intrinsic stem cell hierarchies in carcinoma-derived cell lines, Cancer Res, 65, 8944, 10.1158/0008-5472.CAN-05-0931
Izumiya, 2012, Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells, Anticancer Res, 32, 3847
Moon, 2011, Nanog-induced dedifferentiation of p53-deficient mouse astrocytes into brain cancer stem-like cells, Biochem Biophys Res Commun, 412, 175, 10.1016/j.bbrc.2011.07.070
Chen, 2006, Lymphatic mapping and sentinel node analysis: current concepts and applications, CA Cancer J Clin, 56, 292, 10.3322/canjclin.56.5.292
Trivedi, 2010, Pathologic evaluation of sentinel lymph nodes in oral squamous cell carcinoma, Head Neck, 32, 1437, 10.1002/hed.21345
Kayahara, 2002, Non-randomized clinical study comparing chemotherapy plus radiotherapy with radiotherapy alone in neoadjuvant therapy for oral cancer, Gan To Kagaku Ryoho, 29, 911